Investigation of TWK10 Administration on the Effects of Amino Acid Absorption
NCT ID: NCT05412667
Last Updated: 2022-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2021-11-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Coenzyme Q10 Supplementation on Oxidative Stress, Antioxidant Capacity, Inflammatory Responses, Fatigue Elimination, and Exercise Performance in Athletes
NCT03321110
Lysine Oxidation in Response to Arginine Supplementation
NCT02499926
Effects of Sustamine(TM) on Cycling Time Trial Performance
NCT01623947
To Explore the Effects of Different Training Periods and Dietary Pattern on the Gut Microbiota, Metabolites and Protein Expression Levels of Strength and Endurance Athletes and to Find Relevant Biological Indicators.
NCT04710667
Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome
NCT06506630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Pea protein without TWK10 (20g/day)
Placebo
1. 4 days without training: drink 2 hours before bedtime.
2. 3 days of training: drink within 30 minutes after training (uniformly brewed in the laboratory).
3. To analyze the amino acid concentration in blood, drink it immediately before blood collection.
TWK10
Pea protein (20g/day) with TWK10 (10 billion CFU/day)
TWK10
1. 4 days without training: drink 2 hours before bedtime.
2. 3 days of training: drink within 30 minutes after training (uniformly brewed in the laboratory).
3. To analyze the amino acid concentration in blood, drink it immediately before blood collection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TWK10
1. 4 days without training: drink 2 hours before bedtime.
2. 3 days of training: drink within 30 minutes after training (uniformly brewed in the laboratory).
3. To analyze the amino acid concentration in blood, drink it immediately before blood collection.
Placebo
1. 4 days without training: drink 2 hours before bedtime.
2. 3 days of training: drink within 30 minutes after training (uniformly brewed in the laboratory).
3. To analyze the amino acid concentration in blood, drink it immediately before blood collection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy body
Exclusion Criteria
* Alcohol consumption
* Cardiovascular disease
* Neuromuscular disease
* Metabolic disease
* Asthma, pregnant or breastfeeding
* BMI\>27
* Allergic to peanuts .
20 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Synbio Tech Inc.
INDUSTRY
Chi-Chang Huang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chi-Chang Huang
PI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graduate Institute of Sports Science, National Taiwan Sport University
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-035-B1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.